XML 24 R14.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements for Operating Entities and Consolidated Funds
9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Fair Value Measurements for Operating Entities and Consolidated Funds Fair Value Measurements for Operating Entities and Consolidated Funds
The following table presents the assets and liabilities that are measured at fair value on a recurring basis on the accompanying condensed consolidated statements of financial condition by caption and by level within the valuation hierarchy as of September 30, 2021 and December 31, 2020:
 Assets at Fair Value as of September 30, 2021
 Level 1Level 2Level 3Netting (c)Total
  (dollars in thousands) 
Operating Entities
    Securities owned, at fair value 
Government bonds$21,936 $— $— $— $21,936 
Preferred stock11,674 — 106,248 — 117,922 
Common stock3,592,861 79 41,350 — 3,634,290 
Convertible bonds— — 7,363 — 7,363 
Corporate bonds— 120,307 83 — 120,390 
Trade claims— — 5,681 — 5,681 
Term loan— — 12,578 — 12,578 
Warrants and rights21,337 — 13,056 — 34,393 
Private investments— — 361 — 361 
    Receivable on derivative contracts, at fair value
Currency forwards— 1,241 — — 1,241 
Equity swaps— 320,825 — (154,015)166,810 
Options44,132 — 238 — 44,370 
Consolidated Funds
    Securities owned, at fair value
Common stock2,951 — — — 2,951 
$3,694,891 $442,452 $186,958 $(154,015)$4,170,286 
Portfolio funds measured at net asset value (a)138,023 
Consolidated Funds' portfolio funds measured at net asset value (a)100,252 
Carried interest (a)84,312 
Equity method investments (a)40,096 
Total investments $4,532,969 
 Liabilities at Fair Value as of September 30, 2021
 Level 1Level 2Level 3Netting (c)Total
 (dollars in thousands)
Operating Entities
     Securities sold, not yet purchased, at fair value    
Common stock$1,352,771 $— $— $— $1,352,771 
Corporate bonds— 40 — — 40 
Preferred stock6,624 — — — 6,624 
Warrants and rights2,288 — — — 2,288 
    Payable for derivative contracts, at fair value
Futures261 — — 261 
Currency forwards— 22 — — 22 
Equity swaps— 146,837 — (141,280)5,557 
Interest rate swaps— 518 — — 518 
Options37,180 — 3,334 — 40,514 
Accounts payable, accrued expenses and other liabilities
          Contingent consideration liability (b)— — 29,053 — 29,053 
$1,399,124 $147,417 $32,387 $(141,280)$1,437,648 
(a) In accordance with US GAAP, portfolio funds are measured at fair value using the net asset value per share (or its equivalent) as a practical expedient are not classified in the fair value hierarchy. Carried interest and equity method investments presented in the table above are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the condensed consolidated statement of financial condition.
(b) In accordance with the terms of the purchase agreements for acquisitions that closed during the first quarter of 2019 and the fourth quarter of 2020, the Company is required to pay to the sellers a portion of future net income and/or revenues of the acquired businesses, if certain targets are achieved through the periods ended December 31, 2020 and December 31, 2023. For both the Quarton acquisition, completed during the first quarter of 2019, and the MHT acquisition, completed during the fourth quarter of 2020, the Company estimated the contingent consideration liabilities using a combination of Monte Carlo and Discounted Cash Flow methods which require the Company to make estimates and assumptions regarding the future cash flows and profits. Changes in these estimates and assumptions could have a significant impact on the amounts recognized. The undiscounted amounts for the Quarton acquisition can range from $10.1 million to $25.0 million. The undiscounted amounts for the MHT acquisition have no minimum or maximum as it is calculated based on revenue.
(c) Derivatives are reported on a net basis, by counterparty, when a legal right of offset exists under an enforceable netting agreement as well as net of cash collateral received or posted under enforceable credit support agreements. See Note 2f for further information on offsetting of derivative financial instruments.
 Assets at Fair Value as of December 31, 2020
 Level 1Level 2Level 3Netting (c)Total
  (dollars in thousands) 
Operating Entities
    Securities owned, at fair value    
Government bonds$19,721 $— $— $— $19,721 
Preferred stock9,391 — 59,967 — 69,358 
Common stock1,746,407 108 23,786 — 1,770,301 
Convertible bonds— — 6,040 — 6,040 
Corporate bonds— 86,368 135 — 86,503 
Trade claims— — 8,713 — 8,713 
Term loan— — 12,623 — 12,623 
Private investments— — 642 — 642 
Warrants and rights21,154 — 6,547 — 27,701 
    Receivable on derivative contracts, at fair value
Currency forwards— 15 — — 15 
Equity swaps— 64,634 — (62,269)2,365 
Options48,851 — 251 — 49,102 
Consolidated Funds
    Securities owned, at fair value
Common stock1,865 — 2,951 — 4,816 
Warrants and rights— — 5,806 — 5,806 
$1,847,389 $151,125 $127,461 $(62,269)$2,063,706 
Portfolio funds measured at net asset value (a)133,454 
Consolidated Funds' portfolio funds measured at net asset value (a)192,670 
Carried interest (a)82,892 
Equity method investments (a)38,681 
Total investments$2,511,403 
 Liabilities at Fair Value as of December 31, 2020
 Level 1Level 2Level 3Netting (c)Total
 (dollars in thousands)
Operating Entities
Securities sold, not yet purchased, at fair value    
US Government securities$— $— $1,500 $— $1,500 
Common stock699,894 — — — 699,894 
Corporate bonds— 10,654 704 — 11,358 
Preferred stock6,589 — — — 6,589 
Warrants and rights8,774 — — — 8,774 
Payable for derivative contracts, at fair value
Currency forwards— 3,067 — — 3,067 
Equity swaps— 43,560 — (37,033)6,527 
Options62,651 — 3,915 — 66,566 
Accounts payable, accrued expenses and other liabilities
          Contingent consideration liability (b)— — 36,718 — 36,718 
$777,908 $57,281 $42,837 $(37,033)$840,993 
(a) In accordance with US GAAP, portfolio funds are measured at fair value using the net asset value per share (or its equivalent) as a practical expedient are not classified in the fair value hierarchy. Carried interest and equity method investments presented in the table above are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the condensed consolidated statement of financial condition.
(b) In accordance with the terms of the purchase agreements for acquisitions that closed during the first quarter of 2019 and the fourth quarter of 2020, the Company is required to pay to the sellers a portion of future net income and/or revenues of the acquired businesses, if certain targets are achieved through the periods ended December 31, 2020 and December 31, 2023. For both the Quarton acquisition, completed during the first quarter of 2019, and the MHT acquisition, completed during the fourth quarter of 2020, the Company estimated the contingent consideration liabilities using a combination of Monte Carlo and Discounted Cash Flow methods which require the Company to make estimates and assumptions regarding the future cash flows and profits. Changes in these estimates and assumptions could have a significant impact on the amounts recognized. The undiscounted amounts for the Quarton acquisition can range from $10.1 million to $35.1 million. The undiscounted amounts for the MHT acquisition have no minimum or maximum as it is calculated based on revenue.
(c) Derivatives are reported on a net basis, by counterparty, when a legal right of offset exists under an enforceable netting agreement as well as net of cash collateral received or posted under enforceable credit support agreements. See Note 2f for further information on offsetting of derivative financial instruments.
The following table includes a roll forward of the amounts for the three and nine months ended September 30, 2021 and 2020 for financial instruments classified within level 3. The classification of a financial instrument within level 3 is based upon the significance of the unobservable inputs to the overall fair value measurement.
Three Months Ended September 30, 2021
Balance at June 30, 2021Transfers inTransfers outPurchases/(covers)(Sales)/shortsRealized and Unrealized gains/lossesBalance at September 30, 2021Change in unrealized gains/losses relating to instruments still held (1)
(dollars in thousands)
Operating Entities
Preferred stock$105,470 $— $(1,531)(b)$5,880 $(1,000)$(2,571)$106,248 $(2,771)
Common stock41,600 — (4)(b)5,500 (2,928)(2,818)41,350 2,289 
Convertible bonds9,712 — — 2,000 (4,025)(324)7,363 (1,174)
Corporate bonds107 — — — — (24)83 (2)
Options, asset244 — — — — (6)238 (6)
Options, liability3,619 — — — — (285)3,334 (285)
Term Loan12,563 — — 315 — (300)12,578 (300)
Warrants and rights11,631 — — 3,519 — (2,094)13,056 (147)
Trade claims5,719 — — 865 (950)47 5,681 — 
Private investments666 — — 14 (509)190 361 (1)
Contingent consideration liability24,810 — — — — 4,243 29,053 4,243 
Three Months Ended September 30, 2020
Balance at June 30, 2020Transfers inTransfers outPurchases/(covers)(Sales)/shortsRealized and Unrealized gains/lossesBalance at September 30, 2020Change in unrealized gains/losses relating to instruments still held (1)
(dollars in thousands)
Operating Entities
Preferred stock$51,480 $— $(7,744)(g)$5,282 $(3,770)$8,170 $53,418 $2,926 
Common stock14,816 — (3)(f)4,000 — 643 19,456 562 
Convertible bonds5,081 — — — — — 5,081 — 
Corporate bonds758 — (312)(g)72 — 520 22 
Options, asset337 — — — — 14 351 14 
Options, liability2,177 — — — — 777 2,954 777 
Term Loan11,359 — — 245 — 507 12,111 506 
Warrants and rights4,625 (f)— — — 355 4,983 337 
Trade claims7,155 — — 2,516 (648)(18)9,005 (18)
Private investments432 — — 174 — (221)385 (221)
Corporate bond, liability800 — — — — — 800 — 
Government bonds, liability1,500 — — — — — 1,500 — 
Contingent consideration liability27,001 — — — — 3,023 30,024 3,023 
Consolidated Funds
Common stock102,951 — — — — — 102,951 — 
Warrants and rights5,858 — — — — 46 5,904 46 
Convertible bonds— — — 75,000 — 538 75,538 538 
Nine Months Ended September 30, 2021
Balance at December 31, 2020Transfers inTransfers outPurchases/(covers)(Sales)/shortsRealized and Unrealized gains/lossesBalance at September 30, 2021Change in unrealized gains/losses relating to instruments still held (1)
(dollars in thousands)
Operating Entities
Preferred stock$59,967 $— $(1,531)(b)$54,539 $(5,651)$(1,076)$106,248 $(2,107)
Common stock23,786 3,409 (e)(5,358)(b)14,972 (9,401)13,942 41,350 13,680 
Convertible bonds6,040 — — 7,827 (10,955)4,451 7,363 3,771 
Corporate bond135 — — 82 (103)(31)83 (31)
Options, asset251 — — — — (13)238 (13)
Options, liability3,915 — — — — (581)3,334 (581)
Term loan12,623 — — 638 — (683)12,578 (683)
Warrants and rights6,548 2,928 (e)— 6,925 (1,610)(1,735)13,056 (452)
Trade claims8,713 — 3,056 (5,254)(834)5,681 (1,902)
Private investments642 — — 457 (929)191 361 (1)
Corporate bond, liability704 — — — (399)(305)— — 
Government bonds, liability1,500 — — — (1,569)69 — — 
Contingent consideration liability37,952 — — — (11,312)2,413 29,053 2,413 
Consolidated Funds
Common stock2,951 (4,000)(e)— — — 1,049 — — 
Warrants and rights5,806 — — — (4,447)(1,359)— — 
Nine Months Ended September 30, 2020
Balance at December 31, 2019Transfers inTransfers outPurchases/(covers)(Sales)/shortsRealized and Unrealized gains/lossesBalance at September 30, 2020Change in unrealized gains/losses relating to instruments still held (1)
(dollars in thousands)
Operating Entities
Preferred stock$7,835 $45,530 (c)$(7,744)(g)$5,647 $(5,870)$8,020 $53,418 $5,337 
Common stock17,466 — (29)(a)(f)5,798 (3,712)(67)19,456 (1,023)
Convertible bonds2,500 — — 2,581 — — 5,081 — 
Corporate Bond, asset2,421 — (312)(g)592 (1,938)(243)520 (180)
Options, asset336 — — — — 15 351 15 
Options, liability2,920 — — — — 34 2,954 35 
Warrants and rights594 3,636 (a)(c)— — — 753 4,983 753 
Term Loan— 11,149 (c)— 245 — 717 12,111 717 
Trade claim7,083 1,044 (a)(f)— 4,231 (2,863)(490)9,005 (511)
Private investments237 — — 432 — (284)385 (284)
Corporate bond, liability1,000 — — — — (200)800 (200)
Government bonds, liability1,950 — — — — (450)1,500 (450)
Contingent consideration liability30,896 — — — (5,653)4,781 30,024 4,781 
Consolidated Funds
Preferred stock4,393 — (4,000)(d)— — (393)— — 
Common stock— 4,000 (d)— 100,000 — (1,049)102,951 (1,049)
Warrants and rights5,567 — — — — 337 5,904 337 
Convertible bonds— — — 75,000 — 538 75,538 538 
(1) Unrealized gains/losses are reported in Investment income - Securities principal transactions, net in the accompanying condensed consolidated statements of operations.
(a) The security stopped trading on an open market.
(b) The entity in which the Company is invested completed an initial public offering.
(c) The company consolidated an operating entity which holds preferred stock, loans and warrants.
(d) The investment was involved in a reverse merger and preferred stock was converted to common shares.
(e) Fair market value derived using models and private transaction levels.
(f) The transfers between level 1 and level 3 are due to the change in the availability of observable inputs.
(g) The investments were converted to common stock.
Certain assets and liabilities are measured at fair value on a nonrecurring basis and therefore are not included in the tables above.
The Company recognizes all transfers and the related unrealized gain (loss) at the beginning of the reporting period.
Transfers between level 2 and 3 generally relate to whether significant relevant observable inputs are available for the fair value measurements or due to change in liquidity restrictions for the investments.
The following table includes quantitative information as of September 30, 2021 and December 31, 2020 for financial instruments classified within level 3. The table below quantifies information about the significant unobservable inputs used in the
fair value measurement of the Company's level 3 financial instruments.
Quantitative Information about Level 3 Fair Value Measurements
Fair Value
September 30, 2021
Valuation TechniquesUnobservable InputsRangeWeighted Average
Level 3 Assets(dollars in thousands)
Common and preferred stocks$64,414 
Discounted cash flows
Guideline companies
Discount rate
EBITDA Market Multiples
12% - 20%
6.25x - 6.75x
12.5%
6.5x
Options238 
Discounted cash flows
Guideline companies
Discount rate
EBITDA Market Multiples
10% - 13%
6.25x - 6.75x
12.5%
6.5x
Trade claims2,639 Discounted cash flowsDiscount rate
20%
20%
Warrants and rights4,512 
Discounted cash flows
Guideline companies
Discount rate
EBITDA Market Multiples
12% - 13%
6.25x - 6.75x
12.5%
6.5x
Corporate, convertible bonds and term loan12,578 
Discounted cash flows
Guideline companies
Discount rate
EBITDA Market Multiples
12% - 13%
6.25x - 6.75x
12.5%
6.5x
Other level 3 assets (a)102,577 
Total level 3 assets $186,958 
Level 3 Liabilities
Options3,334 Option pricing modelsVolatility
35%
35%
Contingent consideration liability29,053 
Discounted cash flows
Monte Carlo simulation
Discount rate
Volatility
7% - 15%
19% - 20%
13%
20%
Total level 3 liabilities$32,387 
Quantitative Information about Level 3 Fair Value Measurements
Fair Value at December 31, 2020Valuation TechniquesUnobservable InputsRangeWeighted Average
Level 3 Assets(dollars in thousands)
Common and preferred stocks$65,735 
Discounted cash flows
Guideline companies
Discount rate
EBITDA Market Multiples
10% - 12%
6.25x - 6.75x
11%
6.5x
Trade claims3,500 Discounted cash flowsDiscount rate
15%
15%
Warrants and rights11,217 
Discounted cash flows
Guideline companies
Discount rate
EBITDA Market Multiples
4% - 11%
6.25x - 6.75x
7%
6.5x
Options251 
Discounted cash flows
Guideline companies
Discount rate
EBITDA Market Multiples
10% - 12%
6.25x - 6.75x
11%
6.5x
Corporate, convertible bonds and term loan12,623 
Discounted cash flows
Guideline companies
Discount rate
EBITDA Market Multiples
10% - 12%
6.25x - 6.75x
11%
6.5x
Other level 3 assets (a)34,135 
Total level 3 assets $127,461 
Level 3 Liabilities
Options3,915 Option pricing modelsVolatility
35%
35%
Contingent consideration liability 36,718 
Discounted cash flows
Monte Carlo simulation
Discount rate
Volatility
9% - 16%
22% - 24%
15%
22%
Other level 3 liabilities (a)2,204 
Total level 3 liabilities$42,837 
(a)The quantitative disclosures exclude financial instruments for which the determination of fair value is based on prices from recent transactions.
The Company has established valuation policies, procedures and internal control infrastructure over the fair value measurement of financial instruments. In the event that observable inputs are not available, the control processes are designed to ensure that the valuation approach utilized is applicable, reasonable and consistently applied. Where a pricing model is used to determine fair value, these control processes include reviews of the methodology and inputs for both reasonableness and applicability. Consistent with best practices, recently executed comparable transactions and other observable market data are used for the purposes of validating both the model and the assumptions used to calculate fair value. Independent of trading and valuation functions, the Company’s Valuation Committee in conjunction with its Price Verification team, plays an important role in determining that financial instruments are appropriately valued and that fair value measurements are both reasonable and
reliable. This is particularly important where prices or valuations that require inputs are less observable. The Valuation Committee is comprised of senior management, including non-investment professionals, who are responsible for overseeing and monitoring the pricing of the Company's investments.
The US GAAP fair value leveling hierarchy is designated and monitored on an ongoing basis. In determining the designation, the Company takes into consideration a number of factors including the observability of inputs, liquidity of the investment and the significance of a particular input to the fair value measurement. Designations, models, pricing vendors, third party valuation providers and inputs used to derive fair market value are subject to review by the valuation committee and the internal audit group. The Company reviews its valuation policy guidelines on an ongoing basis and may adjust them in light of improved valuation metrics and models, the availability of reliable inputs and information, and prevailing market conditions. The Company regularly reviews a profit and loss report, as well as other periodic reports, and analyzes material changes from period to period in the valuation of its investments as part of its control procedures. The Company also performs back testing on a regular basis by comparing prices observed in executed transactions to previous valuations.
The fair market value for level 3 securities may be highly sensitive to the use of industry-standard models, unobservable inputs and subjective assumptions. The degree of fair market value sensitivity is also contingent upon the subjective weight given to specific inputs and valuation metrics. The Company holds various equity and debt instruments where different weight may be applied to industry-standard models representing standard valuation metrics such as: discounted cash flows, market multiples, comparative transactions, capital rates, recovery rates and timing, and bid levels. Generally, changes in the weights ascribed to the various valuation metrics and the significant unobservable inputs in isolation may result in significantly lower or higher fair value measurements. Volatility levels for warrants and options are not readily observable and subject to interpretation. The interrelationship between unobservable inputs may vary significantly amongst level 3 securities as they are generally highly idiosyncratic. Significant increases (decreases) in any of those inputs in isolation can result in a significantly lower (higher) fair value measurement.
Other financial assets and liabilities
The following table presents the carrying values and fair values, at September 30, 2021 and December 31, 2020, of financial assets and liabilities and information on their classification within the fair value hierarchy which are not measured at fair value on a recurring basis. For additional information regarding the financial instruments within the scope of this disclosure, and the methods and significant assumptions used to estimate their fair value (see Note 2e).
 September 30, 2021December 31, 2020Fair Value Hierarchy
 Carrying AmountFair ValueCarrying AmountFair Value
  (dollars in thousands) 
Financial Assets 
Operating companies
Cash and cash equivalents$1,057,123 $1,057,123 $645,169 $645,169 Level 1
Cash collateral pledged48,996 48,996 110,743 110,743 Level 2
Segregated cash177,693 177,693 185,141 185,141 Level 1
Securities purchased under agreements to resell— — 191 204 Level 2
Securities borrowed2,169,056 2,169,056 1,908,187 1,908,187 Level 2
Loans receivable3,479 3,479 (d)7,682 7,682 (d)Level 3
Consolidated Funds
Cash and cash equivalents426 426 417 417 Level 1
Financial Liabilities
Securities sold under agreements to repurchase53,839 56,121 5,036 5,544 Level 2
Securities loaned3,352,456 3,352,456 2,476,414 2,476,414 Level 2
Convertible debt— — 80,808 (a)135,444 (b)Level 2
Notes payable and other debt479,503 (e)515,708 (c)383,067 (e)405,840 (c)Level 2
(a)The carrying amount of the convertible debt includes an unamortized discount of $6.7 million as of December 31, 2020.
(b)The convertible debt includes the conversion option and is based on the last broker quote available.
(c)Notes payable and other debt are based on the last broker quote available.
(d)The fair market value of level 3 loans is calculated using discounted cash flows where applicable.
(e)The carrying amount of the notes payable and other debt includes an unamortized discount and unamortized premium of $1.4 million and $0.3 million as of September 30, 2021, respectively and unamortized premium of $0.4 million as of December 31, 2020.